PD-L1+ PCs showed a decrease in PD-1+ lymphocytes and tumor-infiltrating macrophages (mainly M2 subpopulation), while PTX3 expression inversely correlated to the number of PD-L1+ PC cells [48]. The gene discussed is PTX3; the disease is neoplasm.